lobbying_activities: 628190

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
628190	32e29923-807b-4187-9d8f-7d990385343e	Q2	THE PETRIZZO GROUP, INC.	305932	SEATTLE BIOMEDICAL RESEARCH INSTITUTE	2008	second_quarter	MED	Secure funding to enable SBRI to acquire critical technologies and associated equipment to ensure that its TB drug discovery research delivers on its ultimate goal to shorten the course of TB treatment from 6-9 months down to 2-4 weeks while streamlining the current four-drug treatment regimen.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2008-07-15T11:38:56-04:00